Skip to main content
Clinical Trials/NCT00175461
NCT00175461CompletedPhase 1

Comparison of the Clinical Effectiveness and Cost-effectiveness of the MIS Anterolateral Approach (MIS Watson Jones, G3) Versus Anterolateral Mini or Posterolateral Mini Approaches in Primary Total Hip Arthroplasty

University of British Columbia2 sites in 1 country156 target enrollmentStarted: September 2005Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
156
Locations
2
Primary Endpoint
3-months WOMAC score

Study Overview

Brief Summary

Comparison of the clinical effectiveness and cost-effectiveness of the MIS anterolateral approach (MIS Watson Jones, G3) versus anterolateral mini or posterolateral mini approaches in primary total hip arthroplasty

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
19 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • No contralateral hip symptoms, no major comorbidity

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

3-months WOMAC score

Time Frame: 3 months

Secondary Outcomes

  • Cost-effectiveness at 2-years(Two years)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials